Breast cancer vaccine (Therion Biologics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBreast cancer vaccine (Therion Biologics)
Drug Alias NameHER-2/neu vaccine - TherionTBC NEUCEA vaccine - TherionMUC-1 vaccine - TherionBreast cancer vaccine NY-ESO-1 - Therion Biologics
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion BiologicsNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherion BiologicsNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A